Investment
Features
FeesSafety
Academy
More
Pluang+

Compare KB Financial Group, Inc. (KB) vs Smith & Nephew plc (SNN) Price & Performance

KB Financial Group, Inc.Trade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

KB Financial Group, Inc. vs Smith & Nephew plc — how do they compare? KB Financial Group, Inc. trades at $123.99 (market cap $42.62B), while Smith & Nephew plc trades at $27.21 (market cap $11.10B). The key difference: KB Financial Group, Inc. is far larger — about 3.8× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.95%). Which is the better fit depends on your goals — on Pluang, investors hold KB Financial Group, Inc. for 33 Days and Smith & Nephew plc for 121 Days on average.

KBSNN
Market Cap
$42.62B$11.10B
Volume
164,2911,051,703
Sector
FinancialsHealth
52-Week High
$132.88$37.17
52-Week Low
$77.50$26.42
Typical Hold Time
33 Days121 Days
Enterprise Value
$215.53T$14.13B
Dividend Yield
2.71%2.95%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

KB Financial Group, Inc.

KB Financial Group (KB) trades at $123.07, down 1.33% today, with mixed technical signals showing a neutral overall trend. The company demonstrates strong fundamentals with consistent earnings beats, including Q2 2026 EPS of $3.79 beating expectations of $3.51. Revenue growth has been steady from $17.8T in 2022 to $21.2T in 2025, with net income margins improving to 27.47%. Analyst sentiment is mixed with 33% buy ratings and 67% hold recommendations.

KB presents a compelling value opportunity with a P/E of 9.68 and P/B of 0.94 below industry averages. The main investment thesis centers on continued earnings momentum and South Korean market outperformance, though risks include banking sector volatility and interest rate sensitivity. The stock's current valuation discount to intrinsic value suggests potential upside if earnings growth persists.

Smith & Nephew plc

Smith+Nephew (SNN) trades at $27.24, near its 52-week low of $27.05, with a bearish technical signal despite recent earnings beats. Revenue grew to $6.16B in 2025, with net income margin improving to 10.08%, but the stock faces headwinds from analyst downgrades and CFO departure news. Product launches like the EVOS PELVIC System highlight innovation, yet investor sentiment remains cautious.

The outlook is mixed: strong fundamentals and undervaluation (P/E 18.34) offer upside, but technical weakness and competitive risks temper near-term gains. Key risks include execution challenges and market volatility, while institutional interest (e.g., BlackRock's $505M stake) provides support. Investors should weigh solid profitability against sentiment-driven price pressure.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

KB
100% Buy0% Sell
Avg holding period · 33 Days
SNN

No sentiment data available yet.

About KB Financial Group, Inc.

KB Financial is the parent company of KB Kookmin Bank, Korea's largest commercial bank, with a 13.1% share of loans as of 2021. Its predecessor banks were established in the 1960s as government policy banks and privatized in the 1990s. Its credit card subsidiary KB Kookmin Card is the number-three player behind Shinhan Card and Samsung Card. KB has in recent years expanded its nonbank business by buying LIG Insurance and Hyundai Securities, making KB a top-five player in nonlife insurance and in securities, and most recently by buying Prudential Life Insurance Korea. It also has KB Capital, which provides leasing and installment finance.

Read more on KB →

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN →